Literature DB >> 10727564

Influenza and pneumococcal vaccination: patient perceptions.

P F Findlay1, Y M Gibbons, W R Primrose, G Ellis, G Downie.   

Abstract

The efficacy of the influenza vaccine in reducing mortality and hospital admissions is established, particularly in the elderly. However, up to 50% of those at risk do not receive the vaccine. These patients are also at risk from pneumococcal infection and there is considerable overlap between the target group for each vaccine. This study sought to identify at risk individuals from consecutive admissions to an acute geriatric unit and to gain an insight into their perceptions with regard to vaccination. The awareness of each vaccine was recorded, together with the vaccination history. Seventy four per cent of the final cohort had heard of the influenza vaccine, while only 13% had heard of the pneumococcal vaccine. Fifty per cent perceived themselves to be at risk from influenza and its complications and 87% of the cohort believed it to be a serious infection. Influenza vaccine was judged to confer good protection by 72% of the sample and yet up to 50% believed that the vaccine can make the recipient ill. Influenza is perceived as a serious infection by patients and yet many do not believe themselves to be at particular risk. Although influenza vaccination is believed to confer protection, the decision whether, or not, to accept the vaccine is coloured by many factors, including popular myths and anecdotal information from friends and relatives. The uptake of influenza vaccine is suboptimal and the awareness of the pneumococcal vaccine certainly in the elderly is poor. The need for a comprehensive nationwide education campaign promoting both influenza and pneumococcal vaccine is highlighted.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10727564      PMCID: PMC1741551          DOI: 10.1136/pmj.76.894.215

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  5 in total

1.  Pneumococcal vaccine campaign based in general practice.

Authors:  P McDonald; E H Friedman; A Banks; R Anderson; V Carman
Journal:  BMJ       Date:  1997-04-12

Review 2.  The pneumococcal vaccine after 15 years of use.

Authors:  J V Hirschmann; B A Lipsky
Journal:  Arch Intern Med       Date:  1994-02-28

Review 3.  Prevention of respiratory infections in adults. Influenza and pneumococcal vaccines.

Authors:  N Fiebach; W Beckett
Journal:  Arch Intern Med       Date:  1994-11-28

4.  Influenza vaccination of elderly persons. Reduction in pneumonia and influenza hospitalizations and deaths.

Authors:  W H Barker; J P Mullooly
Journal:  JAMA       Date:  1980-12-05       Impact factor: 56.272

5.  Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations.

Authors:  J C Butler; R F Breiman; J F Campbell; H B Lipman; C V Broome; R R Facklam
Journal:  JAMA       Date:  1993-10-20       Impact factor: 56.272

  5 in total
  8 in total

1.  Cluster randomised controlled trial of an educational outreach visit to improve influenza and pneumococcal immunisation rates in primary care.

Authors:  A Niroshan Siriwardena; Aly Rashid; Mark R D Johnson; Michael E Dewey
Journal:  Br J Gen Pract       Date:  2002-09       Impact factor: 5.386

2.  Uptake of pneumococcal polysaccharide vaccine in at-risk populations in England and Wales 1999-2005.

Authors:  R G Pebody; J Hippisley-Cox; S Harcourt; M Pringle; M Painter; G Smith
Journal:  Epidemiol Infect       Date:  2007-04-20       Impact factor: 2.451

3.  Development and testing of a vaccination message targeted to persons with spinal cord injuries and disorders.

Authors:  Sherri L LaVela; Kenzie A Cameron; Michael Priebe; Frances M Weaver
Journal:  J Spinal Cord Med       Date:  2008       Impact factor: 1.985

4.  Factors influencing childhood influenza immunization.

Authors:  Vincent J Grant; Nicole Le Saux; Amy C Plint; Rhonda Correll; Isabelle Gaboury; Edward Ellis; Theresa W S Tam
Journal:  CMAJ       Date:  2003-01-07       Impact factor: 8.262

5.  A qualitative study of lay beliefs about influenza immunisation in older people.

Authors:  Meirion R Evans; Hayley Prout; Lindsay Prior; Lorna M Tapper-Jones; Chris C Butler
Journal:  Br J Gen Pract       Date:  2007-05       Impact factor: 5.386

6.  A large two-centre study in to rates of influenza and pneumococcal vaccination and infection burden in rheumatoid arthritis in the UK.

Authors:  Sujith Subesinghe; Andrew Ian Rutherford; Fowzia Ibrahim; Helen Harris; James Galloway
Journal:  BMC Musculoskelet Disord       Date:  2016-08-04       Impact factor: 2.362

7.  Variations in influenza vaccination coverage among the high-risk population in Sweden in 2003/4 and 2004/5: a population survey.

Authors:  Madelon W Kroneman; Gerrit A van Essen
Journal:  BMC Public Health       Date:  2007-06-14       Impact factor: 3.295

8.  Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34,892 subjects.

Authors:  Mohammad Madjid; Charles C Miller; Vladimir V Zarubaev; Ivan G Marinich; Oleg I Kiselev; Yury V Lobzin; Alexander E Filippov; Samuel Ward Casscells
Journal:  Eur Heart J       Date:  2007-04-17       Impact factor: 29.983

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.